Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Global Healthcare Contract Development And Manufacturing Organization Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Healthcare Contract Development And Manufacturing Organization Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Healthcare Contract Development And Manufacturing Organization Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Global Healthcare Contract Development And Manufacturing Organization Market, By Services Historical Analysis and Forecast 2024-2032 (USD Million)

  •   1. Contract development
       1.1. Small Molecule
        1.1.1. Preclinical
         1.1.1.1. Bioanalysis and DMPK studies
         1.1.1.2. Toxicology Testing
         1.1.1.3. Other Preclinical Services
        1.1.2. Clinical
         1.1.2.1. Phase I
         1.1.2.2. Phase II
         1.1.2.3. Phase III
         1.1.2.4. Phase IV
        1.1.3. Laboratory Services
         1.1.3.1. Bioanalytical Services
         1.1.3.2. Analytical Services
       1.2. Large Molecule
        1.2.1. Cell Line development
        1.2.2. Process Development
         1.2.2.1. Upstream
          1.2.2.1.1. Microbial
          1.2.2.1.2. Mammalian
          1.2.2.1.3. Others
         1.2.2.2. Downstream
          1.2.2.2.1. MABs
          1.2.2.2.2. Recombinant proteins
          1.2.2.2.3. Others
        1.2.3. Others
      2. Contract manufacturing
       2.1. Small Molecule
       2.2. Large Molecule
        2.2.1. MABs
        2.2.2. Recombinant proteins
        2.2.3. Others
       2.3. High Potency API
       2.4. Finished Dose Formulations
        2.4.1. Solid Dose Formulation
        2.4.2. Liquid Dose Formulation
        2.4.3. Injectable Dose Formulation
       2.5. Medical Devices
        2.5.1. Class I
        2.5.2. Class II
        2.5.3. Class III

• 8.   North America Healthcare Contract Development And Manufacturing Organization Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2024-2032

• 9.   Latin America Healthcare Contract Development And Manufacturing Organization Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2024-2032

• 10.   Europe Healthcare Contract Development And Manufacturing Organization Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.7. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2024-2032

• 11.   Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

• 12.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
       2.1. Saudi Arabia
       2.2. UAE
       2.3. South Africa
       2.4. Egypt
      3. Market Size (USD Million) Forecast for MEA 2024-2032

• 13.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. Catalent Inc.
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Lonza Group Ltd.
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Recipharm AB
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Siegfried Holding AG
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Thermo Fisher Scientific Inc.
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Covance Inc
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Jabil
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Sanmina Corporation
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. IQVIA Holdings Inc.
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. Flex
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview

• 15.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by
                administrations
      5. The overall economic slowdown of the developing and developed nations

• 16.   FutureWise SME Key Takeaway Points for Client